Clinical implications of the interaction between PD-1/PD-L1 and PI3K/AKT/mTOR pathway in progression and treatment of non-small cell lung cancer

The discovery of immune checkpoints has been well known to provide novel clues for cancer treatments. Immunotherapy against the programmed cell death protein-1 (PD-1) /programmed death-ligand-1 (PD-L1), one of the most popular auxiliary treatments in recent years, has been applied in various tumor t...

Descripción completa

Detalles Bibliográficos
Autores principales: Quan, Zihan, Yang, Yang, Zheng, Hongmei, Zhan, Yuting, Luo, Jiadi, Ning, Yue, Fan, Songqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9608206/
https://www.ncbi.nlm.nih.gov/pubmed/36313041
http://dx.doi.org/10.7150/jca.77619

Ejemplares similares

Ejemplares similares